
Scott Lippman, MD, will lead the PreCancer Genome Atlas, an NCI-sponsored effort to map premalignant lesions and how they evolve into invasive cancers.
Scott Lippman, MD, will lead the PreCancer Genome Atlas, an NCI-sponsored effort to map premalignant lesions and how they evolve into invasive cancers.
Copyright © 2023 Biotech Networks, LLC